Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DALTEPARIN Cause End stage renal disease? 58 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 58 reports of End stage renal disease have been filed in association with DALTEPARIN (Fragmin). This represents 1.6% of all adverse event reports for DALTEPARIN.

58
Reports of End stage renal disease with DALTEPARIN
1.6%
of all DALTEPARIN reports
58
Deaths
54
Hospitalizations

How Dangerous Is End stage renal disease From DALTEPARIN?

Of the 58 reports, 58 (100.0%) resulted in death, 54 (93.1%) required hospitalization, and 54 (93.1%) were considered life-threatening.

Is End stage renal disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DALTEPARIN. However, 58 reports have been filed with the FAERS database.

What Other Side Effects Does DALTEPARIN Cause?

Off label use (352) Nausea (316) Abdominal pain (283) Multiple organ dysfunction syndrome (282) Vomiting (282) Hyponatraemia (257) General physical health deterioration (253) Sepsis (252) Constipation (247) Abdominal distension (245)

What Other Drugs Cause End stage renal disease?

OMEPRAZOLE (10,356) ESOMEPRAZOLE (10,231) LANSOPRAZOLE (9,734) PANTOPRAZOLE (8,523) DEXLANSOPRAZOLE (4,800) RABEPRAZOLE (1,295) EMTRICITABINE\TENOFOVIR DISOPROXIL (721) TENOFOVIR DISOPROXIL (558) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (462) TACROLIMUS (361)

Which DALTEPARIN Alternatives Have Lower End stage renal disease Risk?

DALTEPARIN vs DAMOCTOCOG ALFA PEGOL DALTEPARIN vs DANAPAROID DALTEPARIN vs DANAZOL DALTEPARIN vs DANICOPAN DALTEPARIN vs DANTROLENE

Related Pages

DALTEPARIN Full Profile All End stage renal disease Reports All Drugs Causing End stage renal disease DALTEPARIN Demographics